$13.08
0.07[0.54%]
Last update: 9:51AM Get Real Time Here
Teva Pharmaceutical Indus
(NYSE:TEVA)Teva Pharmaceutical Indus Stock (NYSE:TEVA), Earnings Estimates, EPS, and Revenue
Teva Pharmaceutical Indus reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$0.520
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$15.8B
Analyze the earnings history of Teva Pharmaceutical Indus using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/08/2024 | AM | TEVA | Q1 | $0.40 | $0.52 | — | — | $3.66B | — | — | — | Get Alert |
| 01/31/2024 | AM | TEVA | Q4 | $0.71 | $0.77 | $1.00 | 29.87% | $3.88B | $4.01B | $4.46B | 11.15% | Get Alert |
| 11/08/2023 | AM | TEVA | Q3 | $0.59 | $0.61 | $0.60 | -1.64% | $3.60B | $3.72B | $3.85B | 3.49% | Get Alert |
| 08/02/2023 | AM | TEVA | Q2 | $0.68 | $0.52 | $0.56 | 7.69% | $3.79B | $3.71B | $3.88B | 4.53% | Get Alert |
| 05/10/2023 | AM | TEVA | Q1 | $0.55 | $0.56 | $0.40 | -28.57% | $3.66B | $3.63B | $3.66B | 0.85% | Get Alert |
| 02/08/2023 | AM | TEVA | Q4 | $0.77 | $0.71 | $0.71 | 0.00% | $4.10B | $3.93B | $3.88B | -1.17% | Get Alert |
| 11/03/2022 | AM | TEVA | Q3 | $0.59 | $0.62 | $0.59 | -4.84% | $3.89B | $3.83B | $3.60B | -6.14% | Get Alert |
| 07/26/2022 | PM | TEVA | Q2 | $0.59 | $0.57 | $0.68 | 19.30% | $3.91B | $3.78B | $3.79B | 0.16% | Get Alert |
| 05/03/2022 | AM | TEVA | Q1 | $0.63 | $0.55 | $0.55 | 0.00% | $3.98B | $3.75B | $3.66B | -2.37% | Get Alert |
| 02/09/2022 | AM | TEVA | Q4 | $0.68 | $0.73 | $0.77 | 5.48% | $4.45B | $4.29B | $4.10B | -4.43% | Get Alert |
| 10/27/2021 | AM | TEVA | Q3 | $0.58 | $0.65 | $0.59 | -9.23% | $3.98B | $4.03B | $3.89B | -3.55% | Get Alert |
| 07/28/2021 | AM | TEVA | Q2 | $0.55 | $0.59 | $0.59 | 0.00% | $3.87B | $4.04B | $3.91B | -3.22% | Get Alert |
| 04/28/2021 | AM | TEVA | Q1 | $0.76 | $0.59 | $0.63 | 6.78% | $4.36B | $4.02B | $3.98B | -0.95% | Get Alert |
| 02/10/2021 | AM | TEVA | Q4 | $0.62 | $0.63 | $0.68 | 7.94% | $4.47B | $4.37B | $4.45B | 1.92% | Get Alert |
| 11/05/2020 | AM | TEVA | Q3 | $0.58 | $0.58 | $0.58 | 0.00% | $4.26B | $4.07B | $3.98B | -2.26% | Get Alert |
| 08/05/2020 | AM | TEVA | Q2 | $0.60 | $0.53 | $0.55 | 3.77% | $4.34B | $3.93B | $3.87B | -1.53% | Get Alert |
| 05/07/2020 | AM | TEVA | Q1 | $0.60 | $0.59 | $0.76 | 28.81% | $4.29B | $4.15B | $4.36B | 4.99% | Get Alert |
| 02/12/2020 | AM | TEVA | Q4 | $0.53 | $0.61 | $0.62 | 1.64% | $4.56B | $4.35B | $4.47B | 2.71% | Get Alert |
| 11/07/2019 | AM | TEVA | Q3 | $0.68 | $0.58 | $0.58 | 0.00% | $4.53B | $4.22B | $4.26B | 1.04% | Get Alert |
FAQ
When is Teva Pharmaceutical Indus (NYSE:TEVA) reporting earnings?
Teva Pharmaceutical Indus (TEVA) is scheduled to report earnings on May 8, 2024. The last reported earnings were for reported on January 31, 2024 for Q4.
What were the latest earnings per share (EPS) for Teva Pharmaceutical Indus (NYSE:TEVA)?
The Actual EPS was $1.00, which beat the estimate of $0.77.
What were Teva Pharmaceutical Indus’s (NYSE:TEVA) revenues?
The Actual Revenue was $4.5B, which beat the estimate of $4B.
Browse earnings estimates, EPS, and revenue on all stocks.